Tower Research Capital LLC (Trc) Champions Oncology, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 501 shares of CSBR stock, worth $4,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

501

Previous 1,640 69.45%

Holding current value

$4,223

Previous $14,000 71.43%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.2 - $11.7 $9,339 - $13,326	-1,139 Reduced 69.45%	501 $4,000
Q4 2024 Feb 13, 2025	SELL	$3.79 - $8.62 $3,460 - $7,870	-913 Reduced 35.76%	1,640 $14,000
Q3 2024 Nov 14, 2024	BUY	$3.95 - $5.14 $10,084 - $13,122	2,553 New	2,553 $12,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $7.32 $78 - $109	15 Added 250.0%	21 $0
Q2 2023 Aug 14, 2023	SELL	$4.11 - $6.81 $10,895 - $18,053	-2,651 Reduced 99.77%	6 $0
Q1 2023 May 09, 2023	BUY	$4.0 - $4.67 $2,792 - $3,259	698 Added 35.63%	2,657 $10,000
Q4 2022 Feb 10, 2023	BUY	$3.75 - $7.69 $7,278 - $14,926	1,941 Added 10783.33%	1,959 $9,000
Q3 2022 Nov 10, 2022	SELL	$7.21 - $9.47 $108 - $142	-15 Reduced 45.45%	18 $0
Q2 2022 Aug 15, 2022	BUY	$6.81 - $8.31 $224 - $274	33 New	33 $0
Q4 2021 Feb 14, 2022	SELL	$7.76 - $10.23 $907 - $1,196	-117 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.11 - $10.96 $5,083 - $6,115	-558 Reduced 82.67%	117 $1,000
Q2 2021 Aug 16, 2021	SELL	$8.45 - $11.72 $13,215 - $18,330	-1,564 Reduced 69.85%	675 $7,000
Q1 2021 May 17, 2021	SELL	$10.61 - $13.75 $6,801 - $8,813	-641 Reduced 22.26%	2,239 $26,000
Q4 2020 Feb 16, 2021	SELL	$8.39 - $13.27 $33,249 - $52,589	-3,963 Reduced 57.91%	2,880 $31,000
Q3 2020 Nov 16, 2020	BUY	$7.05 - $10.2 $10,955 - $15,850	1,554 Added 29.38%	6,843 $63,000
Q2 2020 Aug 13, 2020	BUY	$6.65 - $9.84 $33,895 - $50,154	5,097 Added 2654.69%	5,289 $50,000
Q1 2020 May 15, 2020	SELL	$4.19 - $8.62 $6,976 - $14,352	-1,665 Reduced 89.66%	192 $1,000
Q4 2019 Feb 07, 2020	SELL	$5.12 - $8.33 $2,908 - $4,731	-568 Reduced 23.42%	1,857 $15,000
Q3 2019 Nov 05, 2019	BUY	$5.4 - $8.99 $4,924 - $8,198	912 Added 60.28%	2,425 $14,000
Q2 2019 Aug 13, 2019	BUY	$7.51 - $10.12 $8,268 - $11,142	1,101 Added 267.23%	1,513 $12,000
Q1 2019 May 14, 2019	SELL	$7.89 - $12.23 $4,986 - $7,729	-632 Reduced 60.54%	412 $4,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $7,610 - $15,941	1,044 New	1,044 $8,000
Q3 2018 Nov 13, 2018	SELL	$5.82 - $17.47 $10,470 - $31,428	-1,799 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$3.6 - $7.27 $165 - $334	46 Added 2.62%	1,799 $11,000
Q1 2018 May 15, 2018	SELL	$3.39 - $4.39 $2,644 - $3,424	-780 Reduced 30.79%	1,753 $6,000
Q4 2017 Feb 09, 2018	BUY	$3.17 - $4.16 $8,029 - $10,537	2,533	2,533 $10,000

Others Institutions Holding CSBR

# of Institutions

Shares Held

5.95M

Call Options Held

43.4K

Put Options Held

2.1K

View Full List

About CHAMPIONS ONCOLOGY, INC.

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $114M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

More about CSBR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Champions Oncology, Inc. Transaction History